One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
Home » Glucagon Market
Glucagon Market
Glucagon Market
Published date: Apr 2022 •Formats:
Request Sample Schedule a Call
  • Home » Glucagon Market

Global Glucagon Market By Product Type (Kits, Injection, Powder/Solution), By Application (Emergency Use, General Use, Diagnostic & Motility, Other Applications), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2029

  • Published date: Apr 2022
  • Report ID: 19431
  • Number of Pages: 212
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Market.us announces publication of its most recently generated research report titled, “Global Glucagon Market by Product Type (Kits, Injection, Powder/Solution), By Application (Emergency Use, General Use, Diagnostic & Motility, Cardiogenic Shock, Other Applications) and by Region – Global Forecast to 2028.”, which offers a holistic view of the Global Glucagon Market through systematic segmentation that covers every aspect of the target market.

    The Global Glucagon Market is projected to be US$ 461.0 Mn in 2019 to reach US$ 837.0 Mn by 2029 at a CAGR of 6.2%.

    The blood sugar level is an essential part of the overall health of the human body. When the blood sugar level becomes low, individuals might feel tired and disoriented. Blood sugar (Glucose) control includes various complex hormonal systems, one of which is glucagon. Glucagon is a metabolic hormone that plays a vital role in controlling blood sugar levels in the human body. Glucagon secreted by alpha cells of the pancreas, which discharged into the bloodstream. Glucagon hormone is also available in drug form which is used to treat severe hypoglycemia (low blood sugar). Glucagon hormone works together with the insulin hormone to maintain blood sugar at the right level in healthy individuals. Glucagon hormonal drug received FDA approval on November 14, 1960. Generally, glucagon is available in the form of intravenous, intramuscular or subdermal injection. Glucagon may cause some side effects such as vomiting, nausea, itching, and rash. Sometimes individuals may get difficulties in breathing and lost consciousness.

    trending_up Total Revenue in 2018

    $461.0 Mn

    trending_up Market CAGR of the Next Ten Years

    6.2%

    no_encryption Market Value (US$ Mn), Share (%) and Growth Rate (%) Comparison 2012-2028
    Purchase this report or a membership to unlock the market value (US$ Mn), share (%) and growth rate (%) comparison for this industry.
    • By Type
    • By Region
    • By Application
    no_encryption Leading Companies Financial Highlights
    Purchase this report or a membership to unlock the leading companies financial highlights for this industry.

    trending_up Market Revenue of the Next Ten Years

    $837.0 Mn

    Increasing prevalence and incidence of hypoglycemia in diabetes patients, coupled with the rising innovations in non-injectable emergency glucagon, are major factors driving the growth of the global market. Growing advancements in therapies & drugs and rising funding by leading organizations to improve health care infrastructure are driving the growth of the target market. Increasing heart-related problems among aging population indirectly fueling global glucagon market growth, as glucagon works as a guardian of the heart against catecholamine surge. Change in the lifestyle pattern, obesity, and bad eating habits such as an unhealthy diet are factors that increase the prevalence of diabetes, which in turn increase demand for glucagon. Moreover, rowing advancements in therapies & drugs and rising funding by leading organizations to improve health care infrastructure are driving the growth of the target market.

    Global Glucagon Market Revenue (US$ Mn), 2019–2029 global glucagon market revenue 2019–2029

    Moreover, increasing support from Food and Drug Administration (US–FDA) for the development of advanced therapies and drugs for the treatment of hypoglycemia is a factor offering lucrative revenue growth opportunity for manufacturers in the target market

    However, Lack of awareness regarding the use of glucagon or low adoption rate in developing countries such as India, China, and Brazil, etc. is another factor that creates a negative impact on market growth

    Global glucagon market is segmented on the basis of product type, application, and region. On the basis of product type, the market is segmented into Kits, Injection, Powder/Solution.  Among product type, Kits segment is account for a major share. On the basis of application, the market is segmented into Emergency Use, General Use, Diagnostic & Motility, Cardiogenic Shock, Other Applications. The Emergency Use segment accounts for a majority share in the Global Glucagon market.

    Global Glucagon Market Attractiveness Index by Application Type, 2019global glucagon market attractiveness index by application type 2019

    On the basis of region, the market is segmented into North America, Europe, APAC, South America and MEA. North America accounts for the majority share in the global Glucagon market, owing fully developed and mature market

    The research report on the Global Glucagon Market includes profiles of some of the major companies such as Novo Nordisk A/S, Eli Lilly & Co, Fresenius SE & Co. KGaA, Torrent Pharmaceuticals Ltd., Xeris Pharmaceuticals, Inc., Svar Life Science AB, Taj Pharmaceuticals Ltd.

    Key Market Segments:

    Type

    • Kits
    • Injection
    • Powder/Solution

    Application

    • Emergency Use
    • General Use
    • Diagnostic & Motility
    • Cardiogenic Shock
    • Other Applications

    Key Market Players included in the report:

    • Novo Nordisk A/S
    • Eli Lilly & Co
    • Fresenius SE & Co. KGaA
    • Torrent Pharmaceuticals Ltd.
    • Xeris Pharmaceuticals Inc.
    • Svar Life Science AB
    • Taj Pharmaceuticals Ltd.

    For the Glucagon Market research study, the following years have been considered to estimate the market size:

    AttributeReport Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Share
    Tweet
    Share
    Pin
    0 Shares
    Glucagon Market
    Glucagon Market
    Published date: Apr 2022
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Novo Nordisk A/S Company Profile
    • Eli Lilly & Co
    • Fresenius SE & Co. KGaA
    • Torrent Pharmaceuticals Ltd.
    • Xeris Pharmaceuticals Inc.
    • Svar Life Science AB
    • Taj Pharmaceuticals Ltd.
  • settingsSettings

Related Reports

  • Functional Gummies Market
  • Bathtubs Market
  • Stone Wool Market
  • Cosmetovigilance Market
  • Birth Control Wearables Маrkеt
  • Geomembrane Market

Our Clients

  • Our Clients
Inquiry Before Buying

Glucagon Market
  • 19431
  • Apr 2022
    • ★★★★★
      ★★★★★
    • (82)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
Multi User
$7,999
$3,499
USD / per unit
save 55%
Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

© 2025 Market.Us. All Rights Reserved.